Delayed Nyse 04:01:01 2023-09-21 pm EDT |
|
5-day change | 1st Jan Change | |
153.43 USD | -0.12% | -0.14% | -5.06% |
Chart calendar AbbVie Inc.
a7fcb4ec5684052c5.8C4BpHAqj8PII5tZNMryZSuD2Gu5gbNVw01nPN0rVOc.iUtW_QF51ZqZQO4pRP7LUG6yt12P09t4ugo4cI8GGb-pHzPiIWC5p5oV9A~68b615f978b163d25178051632649b66
Upcoming events on AbbVie Inc.
Past events on AbbVie Inc.
2023-09-13 10:50 am | Morgan Stanley Global Healthcare Conference |
2023-07-27 09:00 am | Q2 2023 Earnings Call |
2023-07-27 07:38 am | Q2 2023 Earnings Release |
2023-07-12 | Détachement de |
2023-06-14 11:00 am | Goldman Sachs Global Healthcare Conference |
2023-05-19 | LIMITLESS Leaders Summit |
2023-05-09 01:30 pm | Digestive Disease Week - Poster #Tu1733 |
2023-05-09 01:30 pm | Digestive Disease Week - Poster #Tu1705 |
2023-05-09 01:30 pm | Digestive Disease Week - Poster #Tu1730 |
2023-05-09 01:30 pm | Digestive Disease Week - Poster #Tu1710 |
2023-05-09 01:30 pm | Digestive Disease Week Meeting - Poster #Tu1717 |
2023-05-09 12:00 pm | Digestive Disease Week - Oral Presentation #1031 |
2023-05-09 11:00 am | Bank of America Healthcare Conference |
2023-05-09 09:30 am | Digestive Disease Week Meeting - Oral Presentation #947 |
2023-05-08 01:30 pm | Digestive Disease Week Meeting - Poster #Mo1419 |
2023-05-08 01:30 pm | Digestive Disease Week - Poster #Mo2008 |
2023-05-08 01:30 pm | Digestive Disease Week - Poster #Mo2015 |
2023-05-08 01:30 pm | Digestive Disease Week - Poster #Mo2016 |
2023-05-08 01:30 pm | Digestive Disease Week - Poster #Mo2007 |
2023-05-07 01:30 pm | Digestive Disease Week - Poster #Su1769 |
Past dividends on AbbVie Inc.
2023-07-12 | Quarterly 1.48 USD |
2023-04-12 | Quarterly 1.48 USD |
2023-01-11 | Quarterly 1.48 USD |
2022-10-12 | Quarterly 1.41 USD |
2022-07-13 | Quarterly 1.41 USD |
2022-04-12 | Quarterly 1.41 USD |
2022-01-12 | Quarterly 1.41 USD |
2021-10-13 | Quarterly 1.3 USD |
2021-07-13 | Quarterly 1.3 USD |
2021-04-13 | Quarterly 1.3 USD |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 32 733 32 714 0.06% | 33 266 33 255 0.03% | 45 784 45 637 0.32% | 56 122 56 238 -0.21% | 58 054 58 284 -0.4% | 53 428 |
EBITDA Million USD | Released Forecast Spread | 16 358 15 640 4.59% | 17 747 16 811 5.57% | 22 642 22 766 -0.54% | 29 018 29 168 -0.51% | 30 961 31 181 -0.7% | 25 854 |
EBIT Million USD | Released Forecast Spread | 14 593 14 695 -0.69% | 15 730 15 736 -0.04% | 21 976 21 832 0.66% | 28 215 28 167 0.17% | 30 183 30 154 0.1% | 24 999 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 5 197 10 814 -51.94% | 8 426 12 085 -30.28% | 3 398 14 347 -76.32% | 12 989 12 579 3.26% | 13 477 16 796 -19.76% | 12 356 |
Net income Million USD | Released Forecast Spread | 5 687 10 124 -43.83% | 7 882 7 753 1.66% | 4 616 7 357 -37.26% | 11 542 11 140 3.61% | 11 836 14 494 -18.34% | 9 830 |
EPS USD | Released Forecast Spread | 3,66 6,50 -43.66% | 5,28 5,23 0.97% | 2,72 4,27 -36.28% | 6,45 6,25 3.27% | 6,63 8,28 -19.89% | 5,62 |
Announcement Date | 01/25/19 | 02/07/20 | 02/03/21 | 02/02/22 | 02/09/23 | - |
Quarterly results
Fiscal Period | December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Millions USD | Released Forecast Spread | 13 959 13 636 2.37% | 14 342 14 299 0.3% | 14 886 14 960 -0.5% | 13 538 13 613 -0.55% | 14 583 14 640 -0.39% | 14 812 14 944 -0.89% | 15 121 15 337 -1.41% | 12 225 12 230 -0.04% | 13 865 13 520 2.55% | 13 641 | 13 791 | 11 957 | 13 381 | 13 621 |
EBITDA Millions USD | Released Forecast Spread | 7 145 7 061 1.19% | 7 559 7 288 3.72% | 7 506 7 457 0.66% | 7 156 7 115 0.58% | 7 643 8 083 -5.45% | 8 090 8 645 -6.42% | 8 072 8 405 -3.96% | 5 682 5 793 -1.92% | 6 710 6 779 -1.02% | 6 775 | 6 587 | |||
EBIT Millions USD | Released Forecast Spread | 6 944 6 904 0.57% | 7 336 7 134 2.83% | 7 333 7 277 0.77% | 6 958 6 972 -0.21% | 7 440 7 382 0.78% | 7 909 7 843 0.85% | 7 876 7 778 1.26% | 5 503 5 553 -0.9% | 6 520 6 398 1.9% | 6 548 | 6 475 | 5 760 | 6 404 | 6 639 |
Earnings before Tax (EBT) Millions USD | Released Forecast Spread | 475 5 059 -90.61% | 2 610 3 685 -29.17% | 3 960 | 4 019 | ||||||||||
Net income Millions USD | Released Forecast Spread | 766 2 422 -68.37% | 3 179 3 163 0.51% | 4 044 3 810 6.16% | 4 490 3 473 29.3% | 924 4 067 -77.28% | 3 949 5 207 -24.16% | 2 473 3 781 -34.59% | 239 2 405 -90.06% | 2 024 2 570 -21.25% | 2 894 | 2 884 | 1 493 | 1 979 | 2 190 |
EPS USD | Released Forecast Spread | 0,42 1,58 -73.36% | 1,78 1,99 -10.55% | 2,26 2,10 7.79% | 2,51 2,03 23.44% | 0,51 2,13 -76.06% | 2,21 2,87 -22.91% | 1,38 2,71 -49.14% | 0,13 1,42 -90.82% | 1,14 1,43 -20.46% | 1,72 | 1,68 | 0,84 | 1,11 | 1,23 |
Announcement Date | 30/07/21 | 29/10/21 | 02/02/22 | 29/04/22 | 29/07/22 | 28/10/22 | 09/02/23 | 27/04/23 | 27/07/23 | - | - | - | - | - |
More events
Past sector events for AbbVie Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Markets
- Equities
- Stock AbbVie Inc. - Nyse
- Calendar